Allison M. Keeler

1.9k citations

31 papers · 1.0k indexed · h-index 16

Co-authors: Terence R. Flotte Ishani Dasgupta Christian Mueller Miguel Sena‐Esteves Guangping Gao Qin Su Mitchell L. Drumm Craig A. Hodges
Topics: Virus-based gene therapy research (15 papers)CAR-T cell therapy research (9 papers)RNA Interference and Gene Delivery (7 papers)
Cited by: Genetics Molecular Biology
Journals: Human Molecular Genetics Frontiers in Immunology Molecular Therapy
Partner nations: United States France Italy

In The Last Decade

Allison M. Keeler

31 papers receiving 1.0k citations

Peers

Countries citing papers authored by Allison M. Keeler

Since Specialization

Citations

This map shows the geographic impact of Allison M. Keeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison M. Keeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison M. Keeler more than expected).

Fields of papers citing papers by Allison M. Keeler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison M. Keeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison M. Keeler. The network helps show where Allison M. Keeler may publish in the future.

Co-authorship network of co-authors of Allison M. Keeler

This figure shows the co-authorship network connecting the top 25 collaborators of Allison M. Keeler. A scholar is included among the top collaborators of Allison M. Keeler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison M. Keeler. Allison M. Keeler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The curious case of AAV immunology 2025 ·Molecular Therapy ·Allison M. Keeler,(unknown),Sanjay Ram,Katherine A. Fitzgerald,Guangping Gao	7
2	Biodistribution and safety of a single rAAV3B-AAT vector for silencing and replacement of alpha-1 antitrypsin in Cynomolgus macaques 2024 ·Molecular Therapy — Methods & Clinical Development ·Meghan Blackwood,Alisha M. Gruntman,Qiushi Tang,(unknown),(unknown),Oleksandr Kondratov,Damien Marsic,Sergei Zolotukhin,Gwladys Gernoux,Allison M. Keeler,Christian Mueller,Terence R. Flotte	1
3	Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer 2023 ·BioDrugs ·(unknown),Ishani Dasgupta,Terence R. Flotte,Allison M. Keeler	78
4	Redosing Adeno-Associated Virus Gene Therapy to the Central Nervous System 2022 ·Human Gene Therapy ·(unknown),Miguel Sena‐Esteves,(unknown),Allison M. Keeler,Heather Gray‐Edwards	7
5	Regulatory T Cell Therapeutics for Neuroinflammatory Disorders 2022 ·Critical Reviews in Immunology ·(unknown),(unknown),Allison M. Keeler	5
6	Rational Use of Immunosuppressive Corticosteroids in Liver-Directed Adeno-Associated Virus Gene Therapy Studies 2022 ·Human Gene Therapy ·Ishani Dasgupta,Allison M. Keeler	2
7	CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing 2021 ·Human Gene Therapy ·Ishani Dasgupta,Terence R. Flotte,Allison M. Keeler	26
8	Modulating immune responses to AAV by expanded polyclonal T-regs and capsid specific chimeric antigen receptor T-regulatory cells 2021 ·Molecular Therapy — Methods & Clinical Development ·(unknown),Katelyn Sylvia,Meghan Blackwood,(unknown),Qiushi Tang,Manish Muhuri,Alisha M. Gruntman,Guangping Gao,Terence R. Flotte,Allison M. Keeler	27
9	Novel Combinatorial MicroRNA-Binding Sites in AAV Vectors Synergistically Diminish Antigen Presentation and Transgene Immunity for Efficient and Stable Transduction 2021 ·Frontiers in Immunology ·Manish Muhuri,Wei Zhan,Yukiko Maeda,Jia Li,(unknown),Jennifer Chen,Katelyn Sylvia,Ishani Dasgupta,(unknown),(unknown),Allison M. Keeler,(unknown),Ran He,Qin Su,Phillip W.L. Tai,Guangping Gao	30
10	Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus 2020 ·BioResearch open access ·Qiushi Tang,Allison M. Keeler,(unknown),Qin Su,(unknown),(unknown),Guangping Gao,Terence R. Flotte	19
11	Intralingual and Intrapleural AAV Gene Therapy Prolongs Survival in a SOD1 ALS Mouse Model 2019 ·Molecular Therapy — Methods & Clinical Development ·Allison M. Keeler,Marina Zieger,(unknown),(unknown),(unknown),Robert H. Brown,Christian Mueller,Mai K. ElMallah	23
12	Pollen-derived RNAs Are Found in the Human Circulation 2019 ·iScience ·Milka Koupenova,Eric Mick,Heather A. Corkrey,Anupama Singh,(unknown),Olga Vitseva,Daniel Levy,Allison M. Keeler,(unknown),Mai K. ElMallah,Mark Gerstein,Joel Rozowsky,Kahraman Tanrıverdi,Jane E. Freedman	9
13	Systemic Delivery of AAVB1- GAA Clears Glycogen and Prolongs Survival in a Mouse Model of Pompe Disease 2018 ·Human Gene Therapy ·Allison M. Keeler,Marina Zieger,(unknown),(unknown),(unknown),(unknown),Sourav Choudhury,Barry J. Byrne,Miguel Sena‐Esteves,Mai K. ElMallah	41
14	CAR T-Cell Therapy: Progress and Prospects 2017 ·Human Gene Therapy Methods ·Olivia Wilkins,Allison M. Keeler,Terence R. Flotte	49
15	Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector 2015 ·Molecular Therapy ·Sourav Choudhury,(unknown),Damien J. Cabral,Allison M. Keeler,Ellen Sapp,(unknown),Heather Gray‐Edwards,Jacob A. Johnson,Aime K. Johnson,Qin Su,Lorelei Stoica,Marian DiFiglia,Neil Aronin,Douglas R. Martin,Guangping Gao,Miguel Sena‐Esteves	91
16	Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan 2015 ·Human Molecular Genetics ·(unknown),(unknown),Allison M. Keeler,Qin Su,(unknown),Scott A. Shaffer,Zuoshang Xu,Guangping Gao,Miguel Sena‐Esteves	83
17	Long-term Correction of Very Long-chain Acyl-CoA Dehydrogenase Deficiency in Mice Using AAV9 Gene Therapy 2012 ·Molecular Therapy ·Allison M. Keeler,Thomas J. Conlon,Glenn A. Walter,Huadong Zeng,Scott A. Shaffer,(unknown),Kirsten Erger,Travis Cossette,Qiushi Tang,Christian Mueller,Terence R. Flotte	21
18	Lack of Cftr in CD3+lymphocytes leads to aberrant cytokine secretion and hyper-inflammatory adaptive immune responses 2011 ·Christian Müller,(unknown),Allison M. Keeler,(unknown),Craig A. Hodges,Mitchell L. Drumm,Terence R. Flotte,(unknown),(unknown)	3
19	Lack of Cystic Fibrosis Transmembrane Conductance Regulator in CD3+ Lymphocytes Leads to Aberrant Cytokine Secretion and Hyperinflammatory Adaptive Immune Responses 2010 ·American Journal of Respiratory Cell and Molecular Biology ·Christian Mueller,(unknown),Allison M. Keeler,Craig A. Hodges,Mitchell L. Drumm,Terence R. Flotte	102
20	Modulation of Exaggerated-IgE Allergic Responses by Gene Transfer-mediated Antagonism of IL-13 and IL-17e 2009 ·Molecular Therapy ·Christian Mueller,Allison M. Keeler,(unknown),(unknown),Qiushi Tang,Terence R. Flotte	9

About Allison M. Keeler

Allison M. Keeler is a scholar working on Genetics, Business and International Management and Oncology, having authored 31 papers that have together received 1.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (15 papers), CAR-T cell therapy research (9 papers) and RNA Interference and Gene Delivery (7 papers). The work is most often cited by research in Genetics (442 citations), Molecular Biology (618 citations) and Genetics (82 citations). Allison M. Keeler has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Terence R. Flotte, Ishani Dasgupta, Christian Mueller, Miguel Sena‐Esteves, Guangping Gao, Qin Su, Mitchell L. Drumm, Craig A. Hodges, Olivia Wilkins and Marina Zieger. Their work appears in journals such as Human Molecular Genetics, Frontiers in Immunology and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact